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Reforming Health Care
The Paradoxes of Cost
Edward A. Zelinsky, M.A., J.D., M.Phil.*
When I accepted the gracious invitation to deliver the Dr. Arthur Grayson Distinguished
Lecture this evening here at the Southern Illinois University School of Law, I anticipated two
things, one of which has turned out to be true. First, I anticipated that I would feel a wonderful
sense of homecoming upon returning to Illinois, where I was born and spent many of my
summers growing up.
I realize that here in Carbondale, Moline, where I was born and spent summers with my
maternal grandfather, seems somewhat far away. However, having lived and taught in New
York and Connecticut for the last 40 years, I expected that coming here would produce warm
feelings of nostalgia for Illinois—and indeed it has. On the outside, I may look like a gray-haired
law professor but I assure you that, deep inside, is the little boy for whom the highlight of his
year was accompanying his beloved grandfather through Illinois summer evenings as my
grandfather inspected his drive-in movie theaters in Moline and Rock Island.
Although most folks associate Elvis Presley’s film Blue Hawaii with the Aloha State, I
associate that film with the Land of Lincoln, having watched it for 14 nights in a row in the
summer of 1962 at my grandfather’s Moline drive-in. When I accepted the invitation to speak
here, I anticipated that, as I crossed into Illinois today, The King himself would be waiting for me
at the border. And I firmly believe that he was.
But now let me confess the second assumption I held when I agreed to speak here
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tonight: I assumed (incorrectly as it has turned out) that, by now, Congress would have adopted
and the President would have signed federal health care legislation, and that I would be here
tonight pontificating about the implications of this legislation. On this one, I guessed wrong.
So let me explore with you why my judgment on this score proved inaccurate. In the
proverbial nutshell, whatever happens in Washington in the weeks and months ahead, the
United States is fated for the indefinite future to conduct a prolonged and difficult national
debate on health care. The reason for this protracted and arduous argument can be
summarized in a single word: cost. Yet, paradoxically, the rhetoric of unspecified cost reduction
is used to avoid the painful choices needed to prune health care outlays, choices that inevitably
involve agonizing denials of medical services in a world of finite resources.
Medical costs cannot be controlled without denying something to somebody. Yet,
paradoxically, the term “cost” is used in contemporary political discourse to avoid the difficult
choices involved in such denials. It is easier to favor unspecified cost reductions, than to identify
particular service denials that would actually reduce medical care expenditures. Elected officials
are reluctant to deny medical services to cut costs, but health care costs cannot be
meaningfully controlled without such service denials.
Our employer-based system of medical care is a major reason we confront this difficult
situation. Yet, again paradoxically, the employer-based system, though flawed, is the best tool
available to us to control medical care costs because employers must respond to competitive
pressures in the marketplace and thus are better positioned than is government to implement
the painful service denials necessary to curb health care outlays. However, even under the best
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of circumstances, medical care costs are not a problem that will be solved, but rather are a
reality to be permanently and painfully managed and controlled.
That was the nutshell version of my speech. Now comes the real thing.
The underlying economics of American medical care are at this point well-known. As a
society, the United States spends substantially more on medical care than any other nation and
those expenditures are rapidly increasing. If we simply project forward the current rate of
American medical care inflation, at some point in the not-so-distant future, governmentsponsored health care (Medicare for seniors, Medicaid for low income persons) will crowd out
virtually all other government activities. Even if we discount these kinds of projections as
overly-alarmist, increased government spending on medical care will hamper financially the
federal and state governments or result in onerous tax burdens. The predictions for the private
sector are equally dismal, as businesses and families will find increasing outlays for medical care
squeezing their budgets. In recent years, the stagnation of cash wages for large segments of the
American workforce has been caused in significant measure by the increasing costs of
employer-provided medical care, costs that have compelled employers to restrain cash wages
to remain competitive. Hence, the demand, from a variety of perspectives, that we control the
“costs” of medical care.
However, true cost control entails pain. Consider, for example, Medicare’s outlays at the
end of life. Roughly 30% of Medicare expenditures occur during the patient’s last year of life.
Some of this end-of-life care is palliative and thus relatively inexpensive. Some of this care is for
patients who die unexpectedly. However, the American medical system provides aggressive
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treatment at the end-of-life, which other nations do not. We cannot reduce the burden of
medical costs without curbing these end-of-life outlays for aggressive care. Nevertheless, most
Americans, and certainly most Medicare recipients, are not prepared to confront this issue. It is
easier to talk about unspecified “costs” than to terminate care.
The problem came into particular focus for me personally as my family simultaneously
lost two friends to cancer. In one case, a friend my age was diagnosed with terminal cancer.
This individual was covered by employer-provided medical insurance in the United States. He
resisted his disease heroically and for two years received the full panoply of anti-cancer
treatments before succumbing, as the physicians had predicted he would.
At the same time, a much younger man, the son-in-law of a friend of ours covered by
Israel’s national health insurance, was also diagnosed with terminal cancer. Despite his youth
and the fact that he was the father of a young child, the Israeli doctors made no effort to
prolong his life.
The Israeli system did a better job of controlling costs than did the American medical
system. But it did so by denying care. Despite all of the rhetoric about controlling medical costs,
there is no willingness on the part of the American public or United States policymakers to
specify the service denials required to control costs. Hence, we hear anodyne rhetoric about
cost reduction, rhetoric with no substance because specifying substance would make clear the
pain necessary to control our medical outlays.
Consider in this context the recent debate about whether the President proposed to
establish “death panels.” President Obama countered this provocative characterization by
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retorting that he only wants voluntary counseling for older persons confronting end-of-life
issues. No one, the President assured us, wants to “pull the plug on Grandma because we’ve
decided that it is too expensive to let her live anymore.”
The participants on both sides of this debate carefully avoided the crux of the issue, the
need to control end-of-life outlays, particularly as Baby Boomers start queuing up in large
numbers to meet the Grim Reaper. We will need “death panels” to control Medicare’s costs if,
by such panels, we mean authoritative bodies curbing expensive end-of-life treatment from
Medicare. In a world of finite resources, we cannot afford to provide infinite care.
Many senior citizens, notwithstanding the President’s assurances, believe that a serious
effort to reduce Medicare costs would affect the medical services they will receive. These
seniors are correct.
Another source of medical cost inflation in the United States is our use of advanced
medical technology and treatments that the rest of the world considers elective. We
Americans, for example, are the world’s heaviest consumers of MRI services and elective
surgery. Here I invoke an example I know well: my own left knee. When knee pain made it
impossible for me to ski, I was quickly whisked into an MRI and, shortly thereafter, had
orthoscopic surgery at little out-of-pocket cost to me personally. I am now again endangering
myself and others on the slopes. Like many members of the Woodstock generation, I have no
intention of growing old gracefully. From my selfish perspective, I received today’s American
medicine at its best.
A generation ago, I would instead have been told that my skiing days were over. In other
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societies, the national health service would say this to me today or would put me onto a long
waiting list.
In short, controlling medical outlays means taking away services. No one, liberal or
conservative, Democrat or Republican, wants to discuss this reality. It is easier to talk about
unspecified cost reductions, make vague calls for undefined sacrifices, or denounce “rationing”
without explaining how to pay for unlimited medical outlays in a world of limited resources.
Well, you may ask, what about all of the avoidable administrative expenses and
unnecessary procedures of the American medical system? I personally am skeptical of such
diagnoses. Although there undoubtedly are savings to be achieved along these lines, I doubt
that, by themselves, such savings can make more than a modest contribution to controlling
medical costs.
But even if one is more optimistic about the savings potentially to be achieved by
reducing administrative outlays and unnecessary medical procedures, another sobering truth
suggests that such savings will not be obtained painlessly: every unnecessary administrator is a
voter. Every provider of an unneeded service is somebody’s constituent. Savings that are easy
to achieve are achieved easily, which is to say, they have already been implemented.
Another variant of the cost-reduction-is-easy theme invokes some of our nation’s most
prestigious medical institutions, like the Mayo Clinic and the Cleveland Clinic. These institutions,
we are told, consistently obtain better than average medical outcomes at substantially lower
than average costs by changing the financial incentives of physicians. By eschewing the
entrepreneurial, fee-for-service model of medicine, these institutions avoid unnecessary care
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and provide better care.
Sounds good: Better care at lower cost. So why has there not been a clamor for
medicine along these lines from employers providing insurance for their employees and from
the recipients of medical services? It is because we have been down this road once already
when we were told during the 1990s that managed care and health maintenance organizations
were the solutions to our nation’s health care challenges. The public hated it, which is why the
Obama Administration carefully avoids these (quite accurate) descriptions of the models
implemented by the Mayo and Cleveland Clinics. Yes, these prestigious institutions and some
other providers satisfy medical care consumers at lower cost through a managed care model.
However, on the whole, the American people resent their experiences with programs that
provide care through large organizations and restrict patients’ choices.
During the early 1970s, Robert Young portrayed on television Marcus Welby, M.D., the
iconic family physician for my generation. Marcus Welby did not know about managed care. He
practiced with a younger physician, to whom Dr. Welby imparted the same kindly insights he
bestowed every week on his grateful patients. If Marcus Welby had worked for an HMO, he
would not have been Marcus Welby—and Americans still expect to get their medical care from
Marcus Welby.
Proponents of managed care often denounce American medical care as fragmented and
uncoordinated. But another characterization is that our decentralized system encourages
professional autonomy and patient choice.
Much attention was devoted this week to the proposal from Senator Snowe of Maine
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that the so-called “public option” be triggered if the insurance industry fails to control
premiums sufficiently to satisfy congressionally-mandated ratios of premiums to family
incomes. Under this proposal, a federal insurance agency would spring into existence unless
private insurers squeeze their medical insurance premiums enough to satisfy these legislativelyestablished ratios. Whatever the intent behind this proposal, its likely effect will be to force the
insurance industry to pressure individuals to take their medical care through HMOs and other
managed care arrangements that promise to reduce costs by denying services. At the same
time, by forcing the insurance industry to make the difficult decisions necessary to confront
costs, Congress would, under the Snowe proposal, insulate itself from the inevitable backlash as
Americans learn that lower medical costs mean less medical services.
Moreover, although the physicians at the Mayo and Cleveland Clinics are among the
nation’s (indeed, the world’s) outstanding
caregivers, physicians themselves often respond poorly when placed into managed care
organizations. In the late 1990s, many hospitals acquired family, internal medicine, and
pediatric practices to integrate such practices into managed care networks centered around
these hospitals. Many of these acquisitions of medical practices flopped. Physicians who in
private practice embraced the financial incentives of fee-for-service medicine by providing
aggressive care, reacted to their new standing as salaried employees in managed care networks
by reducing inordinately their professional outputs. In these settings, at least, there was no
Golden Mean.
Some participants in our current national debate about health care argue that universal
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coverage is the gateway to controlling medical care costs. For the moment, let us put aside the
inherent (perhaps deliberate) imprecision of terms like “universal coverage.” Those traveling
under the banner of “universal coverage” can marshal compelling stories of uninsured
individuals who failed up front to receive relatively simple forms of care, resulting in more
serious and costly medical problems down the road. In these instances, comparatively cheap
treatment earlier would have prevented more expensive treatment later. However, it does not
follow from these genuinely troubling anecdotes that universal coverage will, in the short run
or in the long run, save money.
Indeed, the evidence suggests otherwise. For example, Massachusetts’ innovative effort
to approach universal coverage has proved substantially more expensive for the state treasury
than had originally been predicted. This is not surprising; individuals previously lacking medical
insurance use more medical services once they are covered. Availability increases usage. There
may be strong arguments for universal coverage, but cost control is not among them.
Consider one final diagnosis of our medical cost problem—that there is no problem. The
mere fact that a society spends more on a particular service or good is not evidence of a
problem; it may also reflect reasonable preferences and opportunities. For example, Americans
spend more on personal computers today than they did 50 years ago when such computers did
not exist. Nevertheless, there is no sense of crisis about the portion of our gross national
product absorbed by personal computers.
Similarly, the argument goes, it is not a problem that an aging population spends more
on medical care but, rather, is a reflection of our preferences and opportunities as a society. It

10

is good, from this vantage, that we fixed my knee with technologies unavailable when I was a
youngster sitting in my grandfather’s drive-in. It is humane, from this perspective, that we fight
to the end-of-life with expensive medical treatment, for we thereby reaffirm our commitment
to human life. At a minimum, these are plausible choices about resource allocation.
Mushy moderate that I am, let me acknowledge the elements of truth in this analysis.
Good modern medicine is, under any conceivable circumstance, labor-intensive and
technologically-sophisticated, which is to say, expensive. An aging, affluent population will
require more medical services as it grows older. Medical costs are not a problem that is going
to be solved, but a reality to be continuously and permanently managed and controlled. Mr.
Obama’s rhetoric about being the last president to address health care is clever but
unpersuasive. Presidents and the American public will grapple with health care policy into the
indefinite future.
Indeed, the numbers indicate that health care costs must be managed and controlled as
far as the eye can see. Such costs cannot be eliminated at a single stroke, nor can such costs be
passively accepted. If escalating outlays on personal computers were reasonably perceived as
depressing cash compensation for working Americans, we would identify this as a national
challenge. If projections of continually increasing spending on personal computers showed
government budgets overtaken by such spending, we would label this a social problem. So, too,
if United States employers credibly viewed spiraling costs for personal computers as among
their most daunting challenges. In that case, we would be talking about the need to control the
costs of personal computer outlays.
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To put this part of my argument another way, democratic government has many
strengths, but saying “no” to voters is not one of them. Thus, we have the unedifying spectacle
of elected officials promising to control medical costs painlessly. The absence of pain is a
prescription for not controlling costs.
Because I criticize our political leaders for their unspecific discussion of health care
costs, let me be specific in my criticism. Indeed, let me be bi-partisan in my criticism to
demonstrate how widespread is the refusal to confront the pain inherent in genuine cost
control.
On the Republican side, Governor Palin recently lambasted the President’s health care
proposals, complaining that those proposals “will ultimately lead to rationing of...health care
by...death panels.” The President, Governor Palin warned, would “empower unelected
bureaucrats to make decisions affecting life or death health-care matters.” Instead, Governor
Palin favors a consumer-driven strategy including vouchers for Medicare participants to
purchase their own coverage from insurance companies and more competition in the insurance
market by permitting individuals to buy their medical coverage across state lines.
I happen to think that both of these proposals merit consideration. However, neither is
a prescription for painless cost control, because cost control cannot be painless. Suppose that
Medicare recipients could purchase their own insurance coverage and all buyers of medical
insurance could shop in a nationwide market. In such a world, costs would be controlled only if
“unelected bureaucrats” in the insurance industry draw lines and deny services. In a world of
finite resources, someone must say “no.” Governor Palin, I respectfully suggest, does not
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confront this reality.
My Democratic exemplar of the refusal to face the inconvenient truth of cost control is
the President himself. In his recent speech to Congress, he acknowledged that Medicare outlays
must be curbed. However, he maintains that all that is needed is for an “independent
commission of physicians and medical experts” to root out “waste and fraud.”
The President reiterated this theme during his blitz of television interviews over the
recent weekend. Medical insurance premiums, he assured us, can be reduced by eliminating
“waste.”
“Waste and fraud” are the bromides politicians conventionally invoke when they want
to appear to be economizing. Of course, there is waste and fraud in government, government
programs, and the medical system. However, if such waste and fraud were simple to eliminate,
they would already have been eliminated. The harsh reality is that we cannot control the costs
of Medicare without denying some, perhaps many, services to seniors. We cannot reduce
insurance premiums without denying services to which Americans with insurance have become
accustomed. President Obama, like Governor Palin, prefers to ignore this reality.
If this seems harsh on our elected officials, I soften my criticism with two observations.
First, I was once an elected official myself, having spent a decade and one-half as an alderman
of the City of New Haven. To quote Abe of my native Illinois, I can criticize politicians “with the
greater freedom because,” having been “a politician myself, none can regard it as personal.”
Second, elected officials behave as they do largely because it corresponds to their
constituents’ preferences. If the American people demanded of their public officials the
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specification of painful sacrifices in the health care arena, such officials would deliver the
goods. However, in my years as an elected officeholder, I do not remember a single voter who
demanded more rigorous confrontation with budgetary realities. To be sure, constituents often
pressed for lower taxes. However, when I asked them where to reduce municipal spending, the
conversation invariably drifted into the kinds of vague generalities about cost savings that
characterize our current national health care debate.
If I am correct that we need to control medical costs but no one wants to confront the
specific denials inherent in effective cost control, then the next question becomes: Are there
solutions to our quandary? To answer this question, we must first explore how we got where
we are today.
It is interesting that, in a debate currently perceived as highly partisan in nature, there is
a consensus among many experts of different ideological stripes that the Internal Revenue
Code is an important cause of our problem by sheltering employees from health care costs.
Under Section 106 of the Code, employer-provided health care, including employer-financed
insurance premiums, is tax-free to the recipient employee, as is the care received through such
employer-provided coverage. Historically, no consideration of health care policy led the federal
government to exclude from employees’ incomes employers’ health care outlays. Rather, that
income tax exclusion was established in a surprisingly casual fashion. Like many decisions with
unanticipated consequences, the income tax exclusion of employer-provided medical care has
now become entrenched, to the detriment of health care cost control. Employer-provided
medical care, by virtue of its tax-free status, fuels higher costs by sheltering employees from
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those costs.
Consider again my left knee. My employer pays substantial premiums for the medical
insurance policy that paid for my MRI and my subsequent surgery. Neither these premiums nor
the resources expended for my care were included in my income for tax purposes. In economic
terms, these premiums and resources are largely invisible to employees. Consequently,
employees have no direct incentive to demand of the employer that it scale back or refine its
medical coverage. In my case, the system gave me no significant financial incentive to assess
whether the preservation of my skiing career was really worth the cost.
By way of contrast, consider what would happen if, starting in 2010, employers’
insurance premiums and other health care outlays for all Americans were reported on Form W2 and were included in employees’ incomes for tax purposes. This would force working
Americans to confront the costs of medical care in a direct and personal way. This, in turn,
would provoke honest discussion at the workplace about the benefits and price of medical care
and would force employees to evaluate carefully the insurance they receive, just as we all must
evaluate the outlays of personal and household budgets in a world of limited resources. If the
costs of employer-financed medical care were made transparent to employees, trade-offs
would be faced and difficult choices made, just as they are in the context of individual domestic
expenditures.
Thus, the employer-based system as molded by the federal tax law is a major reason
United States medical costs escalate—employees are sheltered from direct confrontation with
the costs of the health care services they use. Controlling costs means confronting constraints.
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In short, neither at the ballot box nor at the workplace do the American people face
personally and directly the costs of medical care. Under these circumstances, the surprise is not
that our medical outlays are so uncontrolled. The surprise is that the problem is not even worse
than it is.
But here there is yet more paradox: Employers, because of the competitive pressures
they encounter in the marketplace, confront costs better than governments. Thus, ironically,
employer-provided medical care, a cause of our current quandary, is currently the best tool
available to us for curbing medical outlays. Employers, required to respond to competitive
pressures, are better positioned than governments to implement the painful service denials
necessary to control health care costs.
For evidence that competitive pressures force employers to confront medical costs, let
us start with the rapid growth of so-called “consumer-driven” health care devices in the
workplace—health reimbursement arrangements, flexible spending accounts, and health
savings accounts. The advantages and limitations of these devices would themselves justify
another lecture. My point right now is that, whatever you may think of these devices, when
implemented by employers they reflect a determination to control medical costs, a
determination absent in the political system.
The same is true of the rapid growth of employer-sponsored wellness programs. These
programs are still quite new and have not been subjected to systematic evaluation. On an
anecdotal level, there are encouraging stories of employees who, through such wellness
programs, have lost weight and stopped smoking. Employers report improved employee morale
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from wellness programs, as well as reduced employee absenteeism. However, the main
motivation for these programs is cost. By improving the health profiles of their respective
workforces, employers sponsoring wellness programs hope to reduce their outlays for medical
insurance premiums and other health care expenses.
Again, the issues raised by employer wellness programs could justify their own lecture.
For example, despite their potential advantages, as such wellness programs develop they may
inappropriately intrude the employers sponsoring them into employees’ privacy and family
lives. For now, however, the point is that employers are turning to wellness programs to reduce
medical costs to stay competitive.
Consider finally deductibles, co-payments, and co-insurance provisions by which
employees are required to share with their respective employers the costs of medical care. In
this area, there is a dramatic difference between the private and public sectors. Private sector
employees increasingly absorb part of the cost for their medical coverage and procedures, both
to sensitize employees to such cost and to offset employers’ financial burdens. In contrast, the
recipients of government-financed medicine, including public employees, generally have much
lower deductibles, co-payments, and co-insurance requirements. That difference reflects the
contrasting dynamics of the marketplace and of politics: It is hard for elected officials to impose
costs on their constituents. Private sector employers, however, must surmount costs to survive.
Where does this leave us? Let me suggest a modest five point program to begin to
control medical costs while improving access to medical services. This modest program accepts
the realities that elected officials are reluctant to deny medical services to reduce costs, health
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care costs cannot be meaningfully controlled without such service denials, and, because of the
competitive pressures employers confront in the marketplace, employer-provided health care
represents our best tool for curbing health care outlays.
First, because it is health care we are discussing, our elected officials should be held to
Hippocratic standards: Do no harm. Any innovation that weakens the system of employerprovided insurance should be resisted. Congress and the President seem determined to enact
tax credits to assist lower income individuals to pay for medical insurance. If designed properly,
I favor such credits. In this context, proper design means that, among other features, such
credits should be available to help less affluent employees pay the deductibles, co-payments,
and co-insurance required by their employer-sponsored medical plans.
Second, Congress should make permanent the federal subsidy for former employees
who elect to pay for continued, post-employment health care coverage from their former
employers, so-called COBRA coverage. For two decades, federal law has made employersponsored health care coverage available for former employees for specified periods after they
terminate employment. Unless a firm has fewer than 20 employees, it must permit its former
employees to pay to it the cost of continuing health care coverage. This right enables
terminated employees to purchase—for a limited transition period—continuing medical care
from their erstwhile employers at group rates, rather than pay the higher premiums typically
charged for individual medical insurance policies.
In the American Recovery and Reinvestment Act of 2009 (colloquially known as the
Stimulus Bill), Congress decided to subsidize employees’ COBRA payments for continuing
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medical coverage for employees who have been laid off. In particular, Congress provided for
the federal Treasury to pay 65% of the former employee’s continuation health care premium,
with the employee only paying the remaining 35%. The result of this subsidy for involuntarily
terminated employees has been a significant increase in the number of such terminated
employees electing COBRA coverage from their former employers’ health care plans. Although
Congress enacted this federal subvention of COBRA premiums as a temporary emergency
measure expiring next year, it should be made permanent.
Third, Congress should mandate on a delayed basis a higher eligibility age for Medicare,
as well as increased co-payments and co-insurance for Medicare participants. As I have
indicated, I see no possibility that Congress will impose costs on its constituents. If anything,
Congress seems headed in the opposite direction and is likely to make Medicare drug coverage
more financially attractive for Medicare participants. However, it is possible that Congress
could schedule delayed cost curbs for Medicare in the form of a higher eligibility age to take
effect in the future, along with larger co-payments and co-insurance requirements similarly to
take effect on a deferred basis. Congress would thereby mandate Medicare cost savings for the
future.
Here, an analogy suggests itself, namely, the Social Security reforms Congress and
President Reagan agreed upon in 1983. The political dynamic then was the same as now:
Elected officials do not like to impose costs on their constituents. However, to reduce future
Social Security outlays, Congress passed and President Reagan signed deferred increases in the
Social Security normal retirement age, starting 17 years later in 2000. These increases are
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phased-in over 22 years and will culminate in 2022, when the Social Security normal retirement
age, over this 22 year period, will have been increased in steps from 65 to 67. In effect,
Congress and President Reagan put future Social Security cost savings on autopilot. The
incremental increases in Social Security’s normal retirement age, agreed upon in 1983, are now
taking place automatically with nary a political ripple.
By way of contrast, the Medicare eligibility age remains at 65. Consequently, Medicare
becomes available before full (though not early) Social Security retirement benefits. For
example, individuals like me, born in 1950, will be Medicare eligible when we turn 65 but, by
virtue of the 1983 reforms, will be entitled to full Social Security benefits only if we retire a year
later at age 66. This gap is now scheduled to widen so that, when the 1983 changes are fully
implemented in 2022, individuals born after 1959 will have to be 67 to receive full Social
Security retirement benefits but will still receive Medicare coverage at age 65.
To reduce future Medicare outlays, I propose that, in emulation of the 1983 changes,
Congress now legislate, effective 13 years hence, that the Social Security normal retirement age
and the Medicare eligibility age be reunified at 67. At the same time, Congress should, on a
delayed basis, phase in higher co-payments and co-insurance requirements for Medicare
coverage, thereby requiring of Medicare recipients in the future larger financial contributions
for their medical care—contributions comparable to those currently made by private sector
employees.
Fourth, Congress should place a relatively high cap on the amount of employersponsored medical coverage that is income tax-free under Code Section 106, but should not
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index that cap for inflation. Thus, gradually, more employer-provided health care will become
taxable to the employees receiving such care, forcing them to confront the costs of such care.
Here again, a precedent is suggestive. In 1964, Congress limited the income tax
exclusion for employer-provided group life insurance to the annual premium for the first
$50,000 of coverage. In 1964, $50,000 was a lot of life insurance coverage and, consequently,
this limit initially affected few employees.
Over the years, this cap has stayed the same, while the typical amount of employerprovided life insurance coverage has increased. Today, the formal rule remains as Congress
adopted it in 1964, that is to say, the premium for the first $50,000 of employer-provided group
term life insurance coverage is income tax free to the insured employee. However, the policy
has in practice come full circle given that today $50,000 of group term life insurance is not very
much. As a result, the typical middle income worker pays income tax on a significant part of his
or her employer-financed life insurance—that is, the premium for coverage over $50,000.
I suggest a similar long-term approach to Internal Revenue Code Section 106 and its
income tax exclusion of employer-provided health care outlays, specifically, a high cap that will
affect relatively few taxpayers today but that will, over time, make more Americans’ employerpaid health care income taxable to them. In this way, Congress would spare its constituents
current pain but gradually require that future Americans confront the costs of the employerprovided medical care they receive by including more employer-paid premiums in taxable
income.
Finally, Congress should modify the Employee Retirement Income Security Act (ERISA) to

21

permit the states to regulate employer-provided health care plans. ERISA preemption is yet
another topic that would justify its own lecture. For now, I observe that ERISA prevents the
states from legislating as to employer-provided health care plans. If one favors experimentation
in the area of health care (and I do), then Congress should activate the powers of our federal
system by letting individual states innovate on their own. Of course, the same political dynamic
that prevails in Washington also prevails in the state capitals. Elected officials do not like to
impose costs on their constituents. However, one of the benefits of federalism is the possibility
(albeit not the guarantee) that some of the fifty states will productively experiment.
The foregoing steps will not, by themselves, solve the problem of controlling medical
costs, but such costs not are a problem that will be solved. Rather, such costs will be a
permanent and continuous challenge to manage and control. These modest steps would point
us in the right direction, that is, trying to control costs as we also try to expand accessibility.
Allow me to conclude by coming back to my childhood summers at my grandfather’s
Moline drive-in. When I told you that I saw Blue Hawaii 14 times, I did not quite tell you the
whole truth. I actually saw the first two-thirds of Blue Hawaii 14 times. My grandfather always
insisted that we leave before the movie ended. Consequently, I had no idea how the story came
out.
Then, one day, 25 years later, I was sitting near a television and there he was, the King in
Hawaii. Much to my wife’s annoyance, I was adamant about staying to the end. And what a
shock the end was: Elvis got the girl.
Like Blue Hawaii, I do not expect to see the end of our national debate about health care
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costs for a long time. Indeed, it is likely that this prolonged debate will last beyond my lifetime.
But the permanence of the problem does not absolve us from making our modest contribution
to its management. As the Jewish sage Hillel wisely said: “Yours is not to complete the task, but
neither are you free to desist from it.”
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